Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy

Oncology

Volumn 77, Issue 5, 2009, Pages 285-292

  Koukourakis, Michael I ^a   Giatromanolaki, Alexandra ^a   Winter, Stuart ^b   Leek, Russel ^b   Sivridis, Efthimios ^a   Harris, Adrian L ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Hypoxia inducible factor 1 ; Lactate dehydrogenase; Squamous cell head and neck cancer

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE 5; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HEAD AND NECK CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; ISOENZYMES; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS;

EID: 70449673054     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000259260     Document Type: Article

References (36)

1. Gray LH, Conger AD, Ebert M: The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953; 26: 683.
2. Harrison L, Blackwell K: Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 2004; 9(suppl 5):31-40.
3. Semenza GL, Shimoda LA, Prabhakar NR: Regulation of gene expression by HIF-1. Novartis Found Symp 2006; 272: 2-8.
4. Semenza GL: Intratumoral hypoxia, radiation resistance, and HIF-1. Cancer Cell 2004; 5: 405-406.
5. Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH, Semenza GL: Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001; 61: 2911-2916.
6. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, Turley H, Talks K, Gatter KC, Harris AL: Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002; 53: 1192-1202.
7. Koukourakis MI, Bentzen SM, Giatromanolaki A, Wilson GD, Daley FM, Saunders MI, Dische S, Sivridis E, Harris AL: Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 2006; 24: 727-735.
8. Holbrook JJ, Liljas A, Steindel SJ, Rossman MG: Lactate dehydrogenase; in Boyer PD (ed): The Enzymes, ed 3. New York, Academic Press, 1975, vol 11, pp 191-292.
9. Firth JD, Ebert BL, Ratcliffe PJ: Hypoxic regulation of lactate dehydrogenase A: interaction between hypoxia-inducible factor 1 and cAMP response elements. J Biol Chem 1995; 270: 21021-21027.
10. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A: Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996; 271: 32529-32537.
11. Zaman K, Ryu H, Hall D, Lin KI, Miller MP, Marquis JC, Baraban JM, Semenza GL, Ratan RR: Protection from oxidative stressinduced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/ cip1), and erythropoietin. J Neurosci 1999; 19: 9821-9830.
12. Koukourakis MI, Giatromanolaki A, Sivridis E, Tumour and Angiogenesis Research Group: Lactate dehydrogenase isoenzymes 1 and 5: differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors. Tumour Biol 2003; 24: 199-202.
13. Koukourakis MI, Giatromanolaki A, Danielidis V, Sivridis E: Hypoxia inducible factor (HIF1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy. Int J Radiat Biol 2008; 84: 47-52.
14. Winter SC, Shah KA, Han C, Campo L, Turley H, Leek R, Corbridge RJ, Cox GJ, Harris AL: The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer. Cancer 2006; 107: 757-766.
15. Halestrap AP, Price NT: The proton linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 1999; 343: 281-299.
16. Parkins CS, Strattford MRL, Dennis MF, Dennis MF, Stubbs M, Chaplin DJ: The relationship between extracellular lactate and tumour pH in a murine tumour model of ischaemia-reperfusion. Br J Cancer 1997; 75: 319-323.
17. Yamagata M, Hasuda K, Stamato T, Tannock IF: The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. Br J Cancer 1998; 77: 1726-1731.
18. Pastorekova S, Ratcliffe PJ, Pastorek J: Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia. BJU Int 2008; 101: 8-15.
19. Rozhin J, Sameni M, Ziegler G, Sloane BF: Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res 1994; 54: 6517-6525.
20. Martinez-Zaguilan R, Seftor EA, Seftor RE, et al: Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 1996; 14: 176-186.
21. Hashimoto K: Study on serum LDH and tissue LDH isozyme values in malignant tumors of the head and neck. Nippon Jibiinkoka Gakkai Kaiho 1968; 71: 463-482.
22. Singh SK, Hasan SA, Sharma SC, Chandra K, Ali R: Serum lactate dehydrogenase in head and neck malignancy patients. Indian J Physiol Pharmacol 1993; 37: 93-94.
23. Chatani M, Matayoshi Y, Masaki N, Fujii T, Umatani K, Yoshino K, Sato T: Radiation therapy of the nasopharyngeal carcinoma: treatment results and prognostic factors. Strahlenther Onkol 1993; 169: 527-533. (Pubitemid 23293785)
24. Cheng SH, Jian JJ, Tsai SY, Chan KY, Yen LK, Chu NM, Tan TD, Tsou MH, Huang AT: Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 1998; 41: 755-762.
25. Liaw CC, Wang CH, Huang JS, Kiu MC, Chen JS, Chang HK: Serum lactate dehydrogenase level in patients with nasopharyngeal carcinoma. Acta Oncol 1997; 36: 159-164.
26. Chu NM, Chen HH, Chen PL, Chung YL, Hsieh CI, Tan TD, Huang AT: A prognostic scoring system for locoregional control in nasopharyngeal carcinoma following conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66: 992-1003.
27. Quennet V, Yaromina A, Zips D, Rosner A, Walenta S, Baumann M, Mueller-Klieser W: Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice. Radiother Oncol 2006; 81: 130-135.
28. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller-Klieser W: Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 349-353.
29. Gatenby RA, Gawlinski ET: The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res 2003; 63: 3847-3854.
30. Koiri RK, Trigun SK, Dubey SK, Singh S, Mishra L: Metal Cu(II) and Zn(II) bipyridyls as inhibitors of lactate dehydrogenase. Biometals 2008; 21: 117-126.
31. Pathak C, Vinayak M: Modulation of lactate dehydrogenase isozymes by modified base queuine. Mol Biol Rep 2005; 32: 191-196.
32. Coyle T, Levante S, Shetler M, Winfield J: In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines. J Neurooncol 1994; 19: 25-35.
33. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL: Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway. Report of the Tumour Angiogenesis Research Group. J Clin Oncol 2006; 24: 4301-4308.
34. Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL: Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 2003; 89: 877-885.
35. Zhong XH, Howard BD: Phosphotyrosinecontaining lactate dehydrogenase is restricted to the nuclei of PC12 pheochromocytoma cells. Mol Cell Biol 1990; 10: 770-776.
36. Dai RP, Yu FX, Goh SR, Chng HW, Tan YL, Fu JL, Zheng L, Luo Y: Histone 2B (H2B) expression is confined to a proper NAD+/ NADH redox status. J Biol Chem 2008; 283: 26894-26901.